TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC)

Clinical trial NCT01745770 · COMPLETED

Trial details

NCT number: NCT01745770
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Active Ulcerative Colitis

Start date: 2013-01-01
Primary completion: 2015-03-01
Enrollment: 306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.